Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysis

Lee C.KWu Y.-LDing P.NLord S.JInoue AZhou CMitsudomi TRosell RPavlakis NLinks MGebski VGralla R.JCHIH-HSIN YANG2020-05-262020-05-2620150732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84937158270&doi=10.1200%2fJCO.2014.58.1736&partnerID=40&md5=4a4c0f1129810e4aceeee31043caeb7chttps://scholars.lib.ntu.edu.tw/handle/123456789/495004[SDGs]SDG3Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysisjournal article10.1200/JCO.2014.58.1736258971542-s2.0-84937158270